Accelr8 Technology Corporation Names Dr. Matthew Strobeck to Board of Directors

Published: Jul 11, 2012

DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE Mkt: AXK), a developer of automated diagnostic systems for same-shift identification and antibiotic resistance testing of bacterial and fungal pathogens, announced today that Dr. Matthew Strobeck has been appointed to Accelr8's Board of Directors.

Back to news